Pelabresib Plus Ruxolitinib Combination Therapy in JAK Inhibitor-Naïve Patients with Myelofibrosis in the Phase 3 MANIFEST-2 Study: Preliminary Evidence of Bone Marrow Recovery
Clinical Lymphoma Myeloma and Leukemia(2024)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要